Upstream Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Upstream Bio and other ETFs, options, and stocks.About UPB
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin.
CEOE. Rand Sutherland
CEOE. Rand Sutherland
Employees52
Employees52
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2021
Founded2021
Employees52
Employees52
UPB Key Statistics
Market cap1.62B
Market cap1.62B
Price-Earnings ratio-12.40
Price-Earnings ratio-12.40
Dividend yield—
Dividend yield—
Average volume557.20K
Average volume557.20K
High today$30.27
High today$30.27
Low today$28.36
Low today$28.36
Open price$29.09
Open price$29.09
Volume519.97K
Volume519.97K
52 Week high$33.00
52 Week high$33.00
52 Week low$5.14
52 Week low$5.14
Stock Snapshot
With a market cap of 1.62B, Upstream Bio(UPB) trades at $29.93. The stock has a price-to-earnings ratio of -12.40.
On 2025-12-18, Upstream Bio(UPB) stock moved within a range of $28.36 to $30.27. With shares now at $29.93, the stock is trading +5.5% above its intraday low and -1.1% below the session's peak.
Trading volume for Upstream Bio(UPB) stock has reached 519.97K, versus its average volume of 557.2K.
The stock's 52-week range extends from a low of $5.14 to a high of $33.00.
The stock's 52-week range extends from a low of $5.14 to a high of $33.00.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own UPB. This list is generated using Robinhood data, and it’s not a recommendation.